Enteric glia: A new player in inflammatory bowel diseases

International Journal of Immunopathology and Pharmacology

Volumn 28, Issue 4, 2015, Pages 443-451

  Capoccia, E ^a   Cirillo, C ^b   Gigli, S ^a   Pesce, M ^c   D'Alessandro, A ^c   Cuomo, R ^c   Sarnelli, G ^c   Steardo, L ^a   Esposito, G ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

enteric glia; enteric nervous system; inflammatory bowel diseases; nitric oxide; S100B

Indexed keywords

NITRIC OXIDE; PROTEIN S100B; S100B PROTEIN, HUMAN;

ENTERIC GLIAL CELL; GLIA CELL; HOMEOSTASIS; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE MUCOSA; MUCOSA INFLAMMATION; NERVOUS SYSTEM INFLAMMATION; PRIORITY JOURNAL; PROTEIN SECRETION; REVIEW; ANIMAL; DRUG EFFECTS; GLIA; INFLAMMATORY BOWEL DISEASES; INNERVATION; INTESTINE; PHYSIOLOGY;

ANIMALS; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINES; NEUROGLIA; NITRIC OXIDE; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT;

EID: 84946025205     PISSN: 03946320     EISSN: 20587384     Source Type: Journal    
DOI: 10.1177/0394632015599707     Document Type: Review

References (71)

1. Rhodes JM, Campbell BJ, (2002) Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared. Trends in Molecular Medicine 8: 10-16.
2. M'Koma AE, (2013) Inflammatory bowel disease: An expanding global health problem. Clinical Medicine Insights Gastroenterology 6: 33-47.
3. Fascì-Spurio F, Aratari A, Margagnoni G, et al. (2012) Oral beclomethasone dipropionate: A critical review of its use in the management of ulcerative colitis and Crohn's disease. Current Clinical Pharmacology 7: 131-136.
4. Hanauer SB, Stathopoulos G, (1991) Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease. Drug Safety 6: 192-219.
5. Engel MA, Neurath MF, (2010) New pathophysiological insights and modern treatment of IBD. Journal of Gastroenterology 45: 571-583.
6. Ham M, Moss AC, (2012) Mesalamine in the treatment and maintenance of remission of ulcerative colitis. Expert Review of Clinical Pharmacology 5 (2): 113-123.
7. Ford AC, Achkar JP, Khan KJ, et al. (2011) Efficacy of 5-aminosalicylates in ulcerative colitis: Systematic review and meta-analysis. American Journal of Gastroenterology 106: 601-616.
8. Spurio FF, Aratari A, Margagnoni G, et al. (2012) Early treatment in Crohn's disease: Do we have enough evidence to reverse the therapeutic pyramid? Journal of Gastrointestinal and Liver Diseases 21: 67-73.
9. Rosh JR, Gross T, Mamula P, et al. (2007) Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: A cautionary tale? Inflammatory Bowel Diseases 13: 1024-1030.
10. Guerra I, Bermejo F, (2014) Management of inflammatory bowel disease in poor responders to infliximab. Clinical and Experimental Gastroenterology 7: 359-367.
11. Frolkis A, Dieleman L, Barkema DVM, et al. (2013) Environment and the inflammatory bowel diseases. Canadian Journal of Gastroenterology 27 (3): e18-e24.
12. Molodecky NA, Kaplan GG, (2010) Environmental risk factors for inflammatory bowel disease. Gastroenterology & Hepatology 6 (5): 339-346.
13. Pastorelli L, De Salvo C, Mercado JR, et al. (2013) Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: Lessons learned from animal models and human genetics. Frontiers in Immunology 4: 280.
14. Rescigno M, (2011) The intestinal epithelial barrier in the control of homeostasis and immunity. Trends in Immunology 32: 256-264.
15. Shih DQ, Targan SR, (2008) Immunopathogenesis of inflammatory bowel disease. World Journal of Gastroenterology 14 (3): 390-400.
16. Nikolaus S, Bauditz J, Gionchetti P,. (1998) Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation. Gut 42 (4): 470-476.
17. Cobrin GM, Abreu MT, (2005) Defects in mucosal immunity leading to Crohn's disease. Immunological Reviews 206: 277-295.
18. Nunes T, Bernardazzi C, de Souza HS, (2014) Interleukin-33 and inflammatory bowel diseases: Lessons from human studies. Mediators of Inflammation 2014: 423957.
19. Andoh A, Yagi Y, Shioya M, et al. (2008) Mucosal cytokine network in inflammatory bowel disease. World Journal of Gastroenterology 14 (33): 5154-5161.
20. Scaldaferri F, Fiocchi C, (2007) Inflammatory bowel disease: Progress and current concepts of etiopathogenesis. Journal of Digestive Diseases 8 (4): 171-178.
21. Geboes K, Collins S, (1998) Structural abnormalities of the nervous system in Crohn's disease and ulcerative colitis. Neurogastroenterology and Motility 10: 189-202.
22. Lakhan SE, Kirchgessner A, (2010) Neuroinflammation in inflammatory bowel disease. Journal of Neuroinflammation 7: 37.
23. Villanacci V, Bassotti G, Nascimbeni R, et al. (2008) Enteric nervous system abnormalities in inflammatory bowel diseases. Neurogastroenterology and Motility 20 (9): 1009-1016.
24. Bassotti G, Villanacci V, Fisogni S, et al. (2007) Enteric glial cells and their role in gastrointestinal motor abnormalities: Introducing the neuro-gliopathies. World Journal of Gastroenterology 13 (30): 4035-4041.
25. Goyal RK, Hirano I, (1996) The enteric nervous system. New England Journal of Medicine 334 (17): 1106-1115.
26. Laranjeira C, Pachnis V, (2009) Enteric nervous system development: Recent progress and future challenges. Autonomic Neuroscience 151 (1): 61-69.
27. Furness JB, Costa M, (1980) Types of nerves in the enteric nervous system. Neuroscience 5 (1): 1-20.
28. Gabella G, (1981) Ultrastructure of the nerve plexuses of the mammalian intestine: The enteric glial cells. Neuroscience 6 (3): 425-436.
29. Rühl A, Nasser Y, Sharkey KA, (2004) Enteric glia. Neurogastroenterology and Motility 16 Suppl 1: 44-49.
30. Bjorklund H, Dahl D, Seiger A, (1984) Neurofilament and glial fibrillary acid protein-related immunoreactivity in rodent enteric nervous system. Neuroscience 12 (1): 277-287.
31. Ferri GL, Probert L, Cocchia D, et al. (1982) Evidence for the presence of S-100 protein in the glial component of the human enteric nervous system. Nature 297 (5865): 409-410.
32. Hoff S, Zeller F, von Weyhern CW, et al. (2008) Quantitative assessment of glial cells in the human and guinea pig enteric nervous system with an anti-Sox8/9/10 antibody. Journal of Comparative Neurology 509 (4): 356-371.
33. Jessen KR, Mirsky R, (1980) Glial cells in the enteric nervous system contain glial fibrillary acidic protein. Nature 286 (5774): 736-737.
34. Gershon MD, Rothman TP, (1991) Enteric glia. Glia 4 (2): 195-204.
35. Liu YA, Chung YC, Pan ST, et al. (2013) 3-D imaging, illustration, and quantitation of enteric glial network in transparent human colon mucosa. Neurogastroenterology and Motility 25 (5): e324-338.
36. Hanani M, Reichenbach A, (1994) Morphology of horseradish peroxidase (HRP)-injected glial cells in the myenteric plexus of the guinea-pig. Cell and Tissue Research 278 (1): 153-160.
37. Rühl A, (2006) Glial regulation of neuronal plasticity in the gut: Implications for clinicians. Gut 55 (5): 600-602.
38. Geboes K, Rutgeerts P, Ectors N, et al. (1992) Major histocompatibility class II expression on the small intestinal nervous system in Crohn's disease. Gastroenterology 103 (2): 439-447.
39. Koretz K, Momburg F, Otto HF, et al. (1987) Sequential induction of MHC antigens on autochthonous cells of ileum affected by Crohn's disease. American Journal of Pathology 129 (3): 493-502.
40. Bassotti G, Villanacci V, Antonelli E, et al. (2007) Enteric glial cells: New players in gastrointestinal motility? Laboratory Investigation 87 (7): 628-632.
41. Yu YB, Li YQ, (2014) Enteric glial cells and their role in the intestinal epithelial barrier. World Journal of Gastroenterology 20 (32): 11273-11280.
42. Savidge TC, Sofroniew MV, Neunlist M, (2007) Starring roles for astroglia in barrier pathologies of gut and brain. Laboratory Investigations 87 (8): 731-736.
43. Zhang DK, He FQ, Li TK, et al. (2010) Glial-derived neurotrophic factor regulates intestinal epithelial barrier function and inflammation and is therapeutic for murine colitis. Journal of Pathology 222: 213-222.
44. Savidge TC, Newman P, Pothoulakis C, et al. (2007) Enteric glia regulate intestinal barrier function and inflammation via re-lease of S-nitrosoglutathione. Gastroenterology 132 (4): 1344-1358.
45. Cirillo C, Sarnelli G, Esposito G, et al. (2011) S100B protein in the gut: The evidence for enteroglial sustained intestinal inflammation. World Journal of Gastroenterology 17 (10): 1261-1266.
46. Esposito G, Cirillo C, Sarnelli G, et al. (2007) Enteric glial-derived S100B protein stimulates nitric oxide production in celiac disease. Gastroenterology 133 (3): 918-925.
47. Burns AJ, Pachnis V, (2009) Development of the enteric nervous system: Bringing together cells, signals and genes. Neurogastroenterology and Motility 21: 100-102.
48. Von Boyen GB, Steinkamp M, Geerling I, et al. (2006) Proinflammatory cytokines induce neurotrophic factor expression in enteric glia: A key to the regulation of epithelial apoptosis in Crohn's disease. Inflammatory Bowel Diseases 12: 346-354.
49. Sharkey KA, (2015) Emerging roles for enteric glia in gastrointestinal disorders. Journal of Clinical Investigation 125 (3): 918-925.
50. Cabarrocas J, Savidge TC, Liblau RS, (2003) Role of enteric glial cells in inflammatory bowel disease. Glia 41: 81-93.
51. Neunlist M, Van Landeghem L, Bourreille A, et al. (2008) Neuro-glial crosstalk in inflammatory bowel disease. Journal of Internal Medicine 263: 577-583.
52. Cheadle GA, Costantini TW, Lopez N, et al. (2013) Enteric glia cells attenuate cytomix-induced intestinal epithelial barrier breakdown. PLoS One 8 (7): e69042.
53. 12,14-prostaglandin J2. Journal of Physiology 588: 2533-2544.
54. Van Landeghem L, Mahé MM, Teusan R, et al. (2009) Regulation of intestinal epithelial cells transcriptome by enteric glial cells: Impact on intestinal epithelial barrier functions. BMC Genomics 10: 507.
55. Neunlist MP, Aubert P, Bonnaud S, et al. (2007) Enteric glia inhibit intestinal epithelial cell proliferation partly through a TGF-β1-dependent pathway. American Journal of Physiology Gastrointestinal and Liver Physiology 292 (1): G231-241.
56. Cirillo C, Sarnelli G, Esposito G, et al. (2009) Increased mucosal nitric oxide production in ulcerative colitis is mediated in part by the enteroglial derived S100B protein. Neurogastroenterology and Motility 21 (11): e1209-1112.
57. Cornet A, Savidge TC, Cabarrocas J, et al. (2001) Enterocolitis induced by autoimmune targeting of enteric glial cells: A possible mechanism in Crohn's disease? Proceedings of the National Academy of Sciences of the United States of America 98 (23): 13306-13311.
58. Von Boyen GBT, Steinkamp M, Reinshagen M, et al. (2004) Proinflammatory cytokines increase glial fibrillary acidic protein expression in enteric glia. Gut 53 (2): 222-228.
59. Von Boyen G, Steinkamp M, (2010) The role of enteric glia in gut inflammation. Neuron Glia Biology 6 (4): 231-236.
60. Leach ST, Yang Z, Messina I, et al. (2007) Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease. Scandinavian Journal of Gastroenterology 42 (11): 1321-1331.
61. Esposito G, Capoccia E, Turco F, et al. (2014) Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation. Gut 63 (8): 1300-1312.
62. Linehan JD, Kolios G, Valatas V, et al. (2005) Effect of corticosteroids on nitric oxide production in inflammatory bowel disease: Are leukocytes the site of action? American Journal of Physiology Gastrointestinal and Liver Physiology 288 (2): G261-267.
63. Menchen L, Colon AL, Madrigal JL, et al. (2004) Activity of inducible and neuronal nitric oxide synthases in colonic mucosa predicts progression of ulcerative colitis. American Journal of Gastroenterology 99 (9): 1756-1764.
64. Cirillo C, Sarnelli G, Turco F, et al. (2011) Proinflammatory stimuli activates human-derived enteroglial cells and induces autocrine nitric oxide production. Neurogastroenterology and Motility 23 (9): e372-e382.
65. Donato R, (2007) RAGE: A single receptor for several ligands and different cellular responses: the case of certain S100 proteins. Current Molecular Medicine 7 (9): 711-724.
66. Schmidt AM, Yan SD, Yan SF, et al. (2001) The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. Journal of Clinical Investigation 108 (7): 949-955.
67. Esposito G, De Filippis D, Cirillo C, et al. (2006) The astroglial-derived S100beta protein stimulates the expression of nitric oxide synthase in rodent macrophages through p38 MAP kinase activation. Life Sciences 78 (23): 2707-2715.
68. Lam AG, Koppal T, Akama KT, et al. (2001) Mechanism of glial activation by S100B: Involvement of the transcription factor NFkappaB. Neurobiology of Aging 22 (5): 765-772.
69. Turco F, Sarnelli G, Cirillo C, et al. (2014) Enteroglial-derived S100B protein integrates bacteria-induced Toll-like receptor signaling in human enteric glial cells. Gut 63 (1): 105-115.
70. Bassotti G, Villanacci V, Nascimbeni R, et al. (2009) Enteric neuroglial apoptosis in inflammatory bowel diseases. Journal of Crohn's & Colitis 3 (4): 264-270.
71. Esposito G, Capoccia E, Sarnelli G, et al. (2012) The antiprotozoal drug pentamidine ameliorates experimentally induced acute colitis in mice. Journal of Neuroinflammation 9: 277.